IPOs vs Biotechs in Numbers: Using the SinoDrugWatch data, we see 2025 was stronger than commonly perceived: global biotech IPO proceeds surpassed ~$10B by August 2025 ( [93] ), thanks to mega deals in Asia (Hengrui $1.27B in HK, etc.) and significant US listings like Karuna (neurology, $260M) and Theta (CRISPR, $250M)
On the positive side, the 10 mg/mL concentration keeps all doses within a very small syringe
Walgreens Pharmacy does support Medicare patients including the Medicare GLP-1 Bridge program
Semaglutide mechanism of action (source: Edgar181, Public domain, via Wikimedia Commons) Like other GLP 1RAs, semaglutide acts primarily through the GLP 1 receptor
How fast it works depends on your body, how you live, how well you sleep, how much water you drink, and how healthy your skin is in general
& Kili, E